Covestor Ltd Has $93,000 Position in Cabot Co. (NYSE:CBT)

Covestor Ltd boosted its position in shares of Cabot Co. (NYSE:CBTFree Report) by 35.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 831 shares of the specialty chemicals company’s stock after purchasing an additional 218 shares during the period. Covestor Ltd’s holdings in Cabot were worth $93,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of CBT. Earnest Partners LLC raised its stake in shares of Cabot by 2.4% in the second quarter. Earnest Partners LLC now owns 3,363,398 shares of the specialty chemicals company’s stock worth $309,063,000 after acquiring an additional 80,096 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Cabot by 0.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,348,972 shares of the specialty chemicals company’s stock valued at $123,965,000 after acquiring an additional 4,437 shares during the period. American Century Companies Inc. boosted its stake in Cabot by 7.3% during the 2nd quarter. American Century Companies Inc. now owns 976,709 shares of the specialty chemicals company’s stock worth $89,750,000 after acquiring an additional 66,171 shares during the last quarter. Sei Investments Co. grew its holdings in Cabot by 5.9% during the second quarter. Sei Investments Co. now owns 913,259 shares of the specialty chemicals company’s stock valued at $83,919,000 after purchasing an additional 51,178 shares during the period. Finally, Bank of New York Mellon Corp increased its stake in Cabot by 1.8% in the second quarter. Bank of New York Mellon Corp now owns 693,580 shares of the specialty chemicals company’s stock valued at $63,733,000 after purchasing an additional 11,986 shares in the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Price Performance

CBT stock opened at $112.50 on Wednesday. The stock has a market cap of $6.17 billion, a PE ratio of 16.69, a price-to-earnings-growth ratio of 0.98 and a beta of 1.20. The stock has a 50-day moving average price of $109.59 and a two-hundred day moving average price of $101.91. Cabot Co. has a 1 year low of $70.63 and a 1 year high of $117.46. The company has a current ratio of 2.08, a quick ratio of 1.45 and a debt-to-equity ratio of 0.68.

Cabot (NYSE:CBTGet Free Report) last announced its earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01). Cabot had a net margin of 9.51% and a return on equity of 26.60%. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $1.01 billion. During the same period in the prior year, the business posted $1.65 EPS. The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. Equities analysts forecast that Cabot Co. will post 7.7 EPS for the current fiscal year.

Cabot Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Friday, November 29th will be issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.53%. The ex-dividend date is Friday, November 29th. Cabot’s payout ratio is 25.52%.

Insider Activity at Cabot

In other news, EVP Jeff Ji Zhu sold 1,201 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $106.19, for a total transaction of $127,534.19. Following the completion of the transaction, the executive vice president now directly owns 96,000 shares in the company, valued at $10,194,240. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, EVP Hobart Kalkstein sold 5,457 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total value of $548,865.06. Following the completion of the sale, the executive vice president now directly owns 61,688 shares in the company, valued at approximately $6,204,579.04. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Jeff Ji Zhu sold 1,201 shares of Cabot stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $106.19, for a total value of $127,534.19. Following the transaction, the executive vice president now owns 96,000 shares of the company’s stock, valued at $10,194,240. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 48,665 shares of company stock valued at $4,986,299. Corporate insiders own 3.07% of the company’s stock.

Analysts Set New Price Targets

CBT has been the topic of a number of recent analyst reports. UBS Group reduced their price target on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. Mizuho boosted their target price on Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a research note on Tuesday, November 5th. Finally, JPMorgan Chase & Co. lowered Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 price target on the stock. in a research report on Monday. One analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $105.00.

Check Out Our Latest Analysis on Cabot

Cabot Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.